9:00am - 5:00pm
Our Opening Hours Mon. - Fri.
1.800.799.2234
Call Us For Free Consultation
Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies...
Continue readingA Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors...
Continue readingA Study of ABBV-181 in Participants With Advanced Solid Tumors...
Continue readingStudy of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)...
Continue readingPhase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers...
Continue readingStudy of ASTX295 in Patients With Solid Tumors With Wild-Type p53...
Continue readingA Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies...
Continue readingFeasibility of the LUM Imaging System for Peritoneal Surface Malignancies...
Continue readingA Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors...
Continue readingProbe Based Confocal Laser Endomicroscopy During Thoracoscopy for Pleural Carcinomatosis Diagnosis...
Continue reading